Clinical Trials
2 trialsNCT01891981 2023-10-13
Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00587457 2017-07-06
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
MedImmune LLC
Phase 1 Terminated